Société Argenica Therapeutics Limited
Actions
AGN
AU0000150328
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
0,585 AUD | 0,00% | +3,54% | +14,71% |
Métier
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Emma Waldon
DFI | Director of Finance/CFO | - | - |
Meghan Thomas
CTO | Chief Tech/Sci/R&D Officer | - | 04/04/22 |
Bruno Meloni
CTO | Chief Tech/Sci/R&D Officer | - | - |
Celina Chewas
PRN | Corporate Officer/Principal | - | 22/11 |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Terry C. Budge
BRD | Director/Board Member | 72 | - |
Geoff Pocock
BRD | Director/Board Member | - | - |
Dianne Angus
BRD | Director/Board Member | 63 | 01/12 |
McCall Liddy
BRD | Director/Board Member | - | - |
Samantha South
PRN | Corporate Officer/Principal | - | - |
Liz Dallimore
CEO | Chief Executive Officer | - | - |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 99 150 822 | 87 682 620 ( 88,43 %) | 0 | 88,43 % |
Coordonnées société
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+14,71% | 47,51 M | |
+25,69% | 47,86 Md | |
+46,90% | 41,42 Md | |
-3,46% | 40,66 Md | |
-6,20% | 28,92 Md | |
+9,17% | 25,55 Md | |
-20,42% | 19,27 Md | |
+0,17% | 12,15 Md | |
+28,07% | 12,14 Md | |
-1,24% | 11,99 Md |
- Bourse
- Actions
- Action AGN
- Société Argenica Therapeutics Limited